Nectaro Pharma Private Limited Pharmaceutical Import Profile — Papua New Guinea (DGFT 2022–2026)

Name: Nectaro Pharma Private Limited Pharmaceutical Import Records from India — 2 Products, $11.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Nectaro Pharma Private Limited — Pharmaceutical Importer Profile (2026) | 2 Products, $11.5K Trade | TransData Nexus

Nectaro Pharma Private Limited

Pharmaceutical Importer · Papua New Guinea · Antimalarial & Antiparasitic Focus · $11.5K Total Trade · DGFT Verified

Nectaro Pharma Private Limited is a pharmaceutical importer based in Papua New Guinea with a total trade value of $11.5K across 2 products in 2 therapeutic categories. Based on 5 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Nectaro Pharma Private Limited sources from 1 verified Indian supplier, with Nectaro Pharma Private Limited accounting for 100.0% of imports.

Nectaro Pharma Private Limited — Import Portfolio & Supplier Network

Nectaro Pharma Private Limited import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Nectaro Pharma Private Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Nectaro Pharma Private Limited	$353.1K	324	100.0%

Nectaro Pharma Private Limited sources from 1 verified Indian supplier across 226 distinct formulations. The sourcing is highly concentrated — Nectaro Pharma Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Nectaro Pharma Private Limited Import?

Formulation	Value	Ships
Medicine amoxicillin 250MG TAB & 500 MG	$35.8K	3
Medicine cefaclor syrup 250 MG/5ML 100ML	$15.4K	2
Medicine fulvizone 250 & 500MG	$14.3K	3
Medicine fluclox-500 & 250 MG	$14.0K	2
Medicine primadoxin	$13.7K	2
Medicine erythromycin 500MG	$13.0K	2
Medicine maloether - 40MG & 80MG	$10.7K	3
Medicine amoxicilin oral suspension	$10.0K	3
Medicine primaquine 7.5MG	$9.5K	2
Non medicine / polypropylene sutures pp830 883840.841910	$8.5K	1
Medicine paracetamol 500MG TAB	$7.9K	2
Medicine / amoxicillin 250 MG tablet	$7.5K	1
Non medicine / bsorbent gauze swabs BP various	$6.8K	1
Medicine / artemether 40 and 80 MG	$6.0K	1
Medicine chloramphenicol 250MG	$5.2K	3

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Primaquine	Antimalarial & Antiparasitic	$9.5K	2	0.6%	9
2	Savlon	Brand Names & OTC Products	$2.0K	3	2.2%	9

Nectaro Pharma Private Limited imports 2 pharmaceutical products across 2 categories into Papua New Guinea totaling $11.5K.

Nectaro Pharma Private Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Nectaro Pharma Private Limited is a pharmaceutical importer based in Papua New Guinea, specializing in the procurement of finished pharmaceutical formulations. The company is headquartered in Lae, a major industrial city in the Morobe Province. Established in 2019, Nectaro Pharma has been operational for over six years, focusing on the importation of medical supplies and pharmaceuticals to meet the healthcare needs of the local population. (yellowpages.com.pg)

The company operates as a private limited entity, with its registered office located at Post Box No. 592, Section 35, Lot 47, Gurney Street, Eriku, Lae 411, Papua New Guinea. Nectaro Pharma's role in Papua New Guinea's pharmaceutical distribution network is pivotal, serving as a key importer of essential medicines and medical supplies. By sourcing products from international suppliers, including India, the company ensures the availability of critical healthcare products in the local market.

2Distribution Network

Nectaro Pharma Private Limited's distribution network is centered in Lae, Papua New Guinea's industrial hub. The company's registered office is situated at Post Box No. 592, Section 35, Lot 47, Gurney Street, Eriku, Lae 411, indicating a strategic location for logistics and distribution operations. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, the company's presence in Lae suggests access to established transportation infrastructure, facilitating the efficient movement of imported pharmaceutical products within Papua New Guinea.

3Industry Role

In Papua New Guinea's pharmaceutical supply chain, Nectaro Pharma Private Limited functions primarily as a pharmaceutical importer. The company sources finished pharmaceutical formulations from international suppliers, including India, and distributes these products within the local market. By importing essential medicines and medical supplies, Nectaro Pharma plays a crucial role in ensuring the availability of healthcare products to meet the needs of the population.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Nectaro Pharma Private Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Nectaro Pharma Private Limited's sourcing strategy exhibits a high degree of concentration, with a total import value of $12,000 USD from India across five shipments. The top two imported products are Primaquine, valued at $10,000 USD, and Savlon, valued at $2,000 USD. This concentration indicates a reliance on a limited number of products and suppliers, which could pose risks such as supply chain disruptions or price fluctuations.

The shipment data reveals a stable relationship with the Indian supplier, as evidenced by the consistent importation of the same products over multiple shipments. However, the lack of diversification in sourcing may limit Nectaro Pharma's ability to adapt to changes in market demand or supply conditions. To mitigate potential risks, the company might consider exploring additional suppliers or diversifying its product portfolio.

2Supply Chain Resilience

Nectaro Pharma Private Limited's supply chain resilience appears to be moderate, given its concentrated sourcing from a single Indian supplier. The company's importation of finished pharmaceutical formulations, including Primaquine and Savlon, suggests a focus on specific products. While this specialization may streamline operations, it also exposes the company to risks associated with supplier dependency and potential disruptions in the supply chain.

Importing Pharmaceuticals into Papua New Guinea — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Papua New Guinea

1Regulatory Authority & Framework

In Papua New Guinea, the regulation of pharmaceutical products is overseen by the Pharmaceutical Services Standards Branch (PSSB) of the National Department of Health. The PSSB is responsible for administering and implementing the Medicines and Cosmetics Act 1999 and its associated regulations, ensuring that medicinal products and medical devices are safe, effective, and of good quality for use by the population. (health.gov.pg)

The Medicines and Cosmetics Act 1999 provides the legislative framework for the registration, importation, and distribution of pharmaceutical products in Papua New Guinea. This Act outlines the requirements for product registration, compliance licensing, and inspection processes, aiming to uphold the integrity and safety of the pharmaceutical supply chain. (health.gov.pg)

2Import Licensing & GMP

Import licensing in Papua New Guinea is governed by the Customs Prohibited Import Regulations, which stipulate that the importation of restricted drugs is prohibited unless the importer has been granted a valid license. This license must be in force at the time of importation and specifically granted for the importation of the restricted drugs. (customs.gov.pg)

The Medicines and Cosmetics Act 1999 and its regulations require that pharmaceutical establishments, including importers, wholesalers, and distributors, obtain appropriate licenses from the Compliance Licensing & Inspecting Unit (CCLI) of the PSSB. These licenses are contingent upon compliance with Good Manufacturing Practices (GMP) and other regulatory standards. While specific GMP certificate recognition is not detailed in the available sources, adherence to internationally recognized standards is typically expected to ensure product quality and safety. (health.gov.pg)

Nectaro Pharma Private Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Nectaro Pharma Private Limited's product strategy focuses on the importation of specific pharmaceutical products, notably Primaquine and Savlon, which fall under the therapeutic categories of Antimalarial & Antiparasitic and Brand Names & OTC Products, respectively. The company's portfolio concentration, with the top five products accounting for 100% of imports, indicates a targeted approach to meet particular healthcare needs within Papua New Guinea.

The market demand for these products is likely driven by the prevalence of malaria and other parasitic infections in the region, necessitating effective treatment options. Additionally, the inclusion of Brand Names & OTC Products suggests a strategy to cater to consumer preferences for recognized and trusted brands in over-the-counter healthcare products.

2Sourcing Profile

Nectaro Pharma Private Limited's sourcing strategy is characterized by a focus on finished pharmaceutical formulations, specifically targeting products like Primaquine and Savlon. The company's reliance on a single Indian supplier for these products indicates a streamlined procurement process but also highlights potential risks associated with supplier dependency.

India's well-established pharmaceutical industry, known for its adherence to international quality standards and competitive pricing, aligns with Nectaro Pharma's sourcing requirements. However, the company's limited diversification in sourcing may impact its ability to adapt to changes in market demand or supply conditions.

Seller's Guide — How to Become a Supplier to Nectaro Pharma Private Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Nectaro Pharma Private Limited

What products does Nectaro Pharma Private Limited import from India?

Nectaro Pharma Private Limited imports 2 pharmaceutical products across 2 categories. Top imports: Primaquine ($9.5K), Savlon ($2.0K).

Who supplies pharmaceuticals to Nectaro Pharma Private Limited from India?

Nectaro Pharma Private Limited sources from 1 verified Indian suppliers. The primary supplier is Nectaro Pharma Private Limited (100.0% of imports, $353.1K).

What is Nectaro Pharma Private Limited's total pharmaceutical import value?

Nectaro Pharma Private Limited's total pharmaceutical import value from India is $11.5K, based on 5 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Nectaro Pharma Private Limited focus on?

Nectaro Pharma Private Limited imports across 2 categories. The largest: Antimalarial & Antiparasitic (82.6%), Brand Names & OTC Products (17.4%).

Get Full Nectaro Pharma Private Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.